Search Results

There are 7059 results for: content related to: Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin

  1. Injectable and biodegradable poly(organophosphazene) gel containing silibinin: Its physicochemical properties and anticancer activity

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 7, July 2012, Pages: 2382–2391, Jung-Kyo Cho, Jung Won Park and Soo-Chang Song

    Version of Record online : 4 APR 2012, DOI: 10.1002/jps.23137

  2. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways

    Journal of Cellular Biochemistry

    Volume 113, Issue 5, May 2012, Pages: 1733–1743, Jir-You Wang, Chia-Chi Chang, Chao-Ching Chiang, Wei-Ming Chen and Shih-Chieh Hung

    Version of Record online : 15 MAR 2012, DOI: 10.1002/jcb.24043

  3. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization

    Journal of Neuroscience Research

    Volume 93, Issue 5, May 2015, Pages: 755–765, Yujeong Lee, Hee Ra Park, Hye Jeong Chun and Jaewon Lee

    Version of Record online : 9 FEB 2015, DOI: 10.1002/jnr.23544

  4. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells

    Journal of Cellular Physiology

    Volume 210, Issue 2, February 2007, Pages: 385–397, Jun Sik Lee, Sang Gap Kim, Hyung Keun Kim, Tae-Hyung Lee, Young-Il Jeong, Chang-Min Lee, Man-Soo Yoon, Yong Jin Na, Dong-Soo Suh, Nam Cheol Park, In-hak Choi, Gi-Young Kim, Yung Hyun Choi, Hae Young Chung and Yeong-Min Park

    Version of Record online : 20 OCT 2006, DOI: 10.1002/jcp.20852

  5. You have free access to this content
    Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels

    BJU International

    Volume 100, Issue 2, August 2007, Pages: 438–444, Catherine W. Cheung, Paul J. Taylor, Carl M.J. Kirkpatrick, David A. Vesey, Glenda C. Gobe, Clay Winterford, David L. Nicol and David W. Johnson

    Version of Record online : 4 JUL 2007, DOI: 10.1111/j.1464-410X.2007.07012.x

  6. Silibinin protects OTA-mediated TNF-α release from perfused rat livers and isolated rat Kupffer cells

    Molecular Nutrition & Food Research

    Volume 53, Issue 4, April 2009, Pages: 460–466, Lauy Al-Anati, Ebtisam Essid, Roland Reinehr and Ernst Petzinger

    Version of Record online : 20 JAN 2009, DOI: 10.1002/mnfr.200800110

  7. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling

    Journal of Cellular Biochemistry

    Volume 110, Issue 5, 1 August 2010, Pages: 1111–1122, Wen Ai, Yan Zhang, Qi-Zhu Tang, Ling Yan, Zhou-Yan Bian, Chen Liu, He Huang, Xue Bai, Lu Yin and Hongliang Li

    Version of Record online : 1 JUN 2010, DOI: 10.1002/jcb.22623

  8. You have free access to this content
    Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking

    Cellular Microbiology

    Volume 15, Issue 11, November 2013, Pages: 1866–1882, Julie Blaising, Pierre L. Lévy, Claire Gondeau, Capucine Phelip, Mihayl Varbanov, Elodie Teissier, Florence Ruggiero, Stephen J. Polyak, Nicholas H. Oberlies, Tijana Ivanovic, Steeve Boulant and Eve-Isabelle Pécheur

    Version of Record online : 13 JUN 2013, DOI: 10.1111/cmi.12155

  9. Effect of silibinin in human colorectal cancer cells: Targeting the activation of NF-κB signaling

    Molecular Carcinogenesis

    Volume 52, Issue 3, March 2013, Pages: 195–206, Komal Raina, Chapla Agarwal and Rajesh Agarwal

    Version of Record online : 15 NOV 2011, DOI: 10.1002/mc.21843

  10. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2

    Molecular Carcinogenesis

    Volume 54, Issue 9, September 2015, Pages: 730–741, Harold J. Ting, Gagan Deep, Anil K. Jain, Adela Cimic, Joseph Sirintrapun, Lina M. Romero, Scott D. Cramer, Chapla Agarwal and Rajesh Agarwal

    Version of Record online : 24 FEB 2014, DOI: 10.1002/mc.22135

  11. You have full text access to this Open Access content
    Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease

    Journal of Veterinary Internal Medicine

    Volume 27, Issue 1, January/February 2013, Pages: 10–16, E.S. Hackett, D.C. Twedt and D.L. Gustafson

    Version of Record online : 9 NOV 2012, DOI: 10.1111/jvim.12002

  12. High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 547–553, M. Biermer, B. Schlosser, B. Fülöp, F. van Bömmel, A. Brodzinski, R. Heyne, K. Keller, C. Sarrazin and T. Berg

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01572.x

  13. Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells

    Molecular Carcinogenesis

    Volume 30, Issue 4, 2001, Pages: 224–236, Yogesh Sharma, Chapla Agarwal, Ashvani K. Singh and Rajesh Agarwal

    Version of Record online : 30 APR 2001, DOI: 10.1002/mc.1032

  14. You have free access to this content
    Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway

    British Journal of Pharmacology

    Volume 168, Issue 4, February 2013, Pages: 920–931, CH Lin, CH Li, PL Liao, LS Tse, WK Huang, HW Cheng and YW Cheng

    Version of Record online : 24 JAN 2013, DOI: 10.1111/j.1476-5381.2012.02227.x

  15. Silibinin Inhibits Neutrophilic Inflammation and Mucus Secretion Induced by Cigarette Smoke via Suppression of ERK-SP1 Pathway

    Phytotherapy Research

    Volume 30, Issue 12, December 2016, Pages: 1926–1936, Ji-Won Park, Na-Rae Shin, In-Sik Shin, Ok-Kyoung Kwon, Joong-Sun Kim, Sei-Ryang Oh, Jae-hong Kim and Kyung-Seop Ahn

    Version of Record online : 29 JUL 2016, DOI: 10.1002/ptr.5686

  16. Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum

    Phytotherapy Research

    Volume 17, Issue 5, May 2003, Pages: 524–530, Zdeněk Švagera, Nina Škottová, Petr Váňa, Rostislav Večeřa, Karel Urbánek, Marie Belejová, Pavel Kosina and Vilím Šimánek

    Version of Record online : 1 MAY 2003, DOI: 10.1002/ptr.1187

  17. You have free access to this content
    Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1262–1271, Stephen J. Polyak, Peter Ferenci and Jean-Michel Pawlotsky

    Version of Record online : 28 FEB 2013, DOI: 10.1002/hep.26179

  18. Silibinin Is a Potent Sensitizer of UVA Radiation-induced Oxidative Stress and Apoptosis in Human Keratinocyte HaCaT Cells

    Photochemistry and Photobiology

    Volume 88, Issue 5, September/October 2012, Pages: 1135–1140, Sreekanth Narayanapillai, Chapla Agarwal, Cynthia Tilley and Rajesh Agarwal

    Version of Record online : 10 JAN 2012, DOI: 10.1111/j.1751-1097.2011.01050.x

  19. You have free access to this content
    Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model

    Acta Ophthalmologica

    Volume 91, Issue 7, November 2013, Pages: e506–e515, Yi-Hao Chen, Chang-Min Liang, Ching-Long Chen, Jiann-Torng Chen, Yun-Hsiang Chang, Da-Wen Lu, Ke-Hung Chien and Ming-Cheng Tai

    Version of Record online : 13 JUN 2013, DOI: 10.1111/aos.12160

  20. Prostate cancer chemoprevention by silibinin: Bench to bedside

    Molecular Carcinogenesis

    Volume 45, Issue 6, June 2006, Pages: 436–442, Rana P. Singh and Rajesh Agarwal

    Version of Record online : 24 APR 2006, DOI: 10.1002/mc.20223